• 1. Essential effect of the electrolyte on the mechanical and chemical degradation of LiNi0.8Co0.15Al0.05O2 cathodes upon long-term cycling??
  Xiaoming Liu,Zachary D. Hood,Wangda Li,Donovan N. Leonard,Arumugam Manthiram,Miaofang Chi J. Mater. Chem. A, 2021,9, 2111-2119
• 2. Evolutionary de novo design of phenothiazine derivatives for dye-sensitized solar cells?
  Vishwesh Venkatraman,Marco Foscato,Vidar R. Jensen,Bj?rn K?re Alsberg J. Mater. Chem. A, 2015,3, 9851-9860
• 3. Evolution and characterization of a benzylguanine-binding RNA aptamer?
  J. Xu,T. J. Carrocci,A. A. Hoskins Chem. Commun., 2016,52, 549-552
• 4. Emerging investigator series: bacteriophages as nano engineering tools for quality monitoring and pathogen detection in water and wastewater
  Fereshteh Bayat Environ. Sci.: Nano, 2021,8, 367-389
• 5. Fe(iii)-mediated isomerization of α,α-diarylallylic alcohols to ketones via radical 1,2-aryl migration?
  Ziyang Deng,Changwei Chen,Sunliang Cui RSC Adv., 2016,6, 93753-93755

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Azoles 2,4,5-trisubstituted thiazoles
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Azoles Thiazoles 2,4,5-trisubstituted thiazoles

Introduction to Amthamine Dihydrobromide (CAS No. 142457-00-9) in Modern Chemical and Biomedical Research

Amthamine Dihydrobromide, identified by the chemical compound code CAS No. 142457-00-9, represents a significant compound in the realm of chemical and biomedical research. This compound has garnered attention due to its unique structural properties and potential applications in therapeutic and diagnostic contexts. The dihydrobromide salt form of Amthamine is particularly studied for its stability and bioavailability, making it a valuable candidate for further exploration in drug development.

The molecular structure of Amthamine Dihydrobromide incorporates specific functional groups that contribute to its reactivity and interaction with biological systems. Recent studies have highlighted the compound's potential role in modulating cellular pathways, particularly those involved in neurodegenerative disorders. Researchers have observed promising results in preclinical trials where Amthamine Dihydrobromide demonstrated the ability to interact with neurotransmitter receptors, suggesting a possible therapeutic benefit in conditions such as Alzheimer's disease and Parkinson's disease.

In the context of biomedical research, the investigation of Amthamine Dihydrobromide has been complemented by advanced spectroscopic techniques and computational modeling. These methodologies have enabled scientists to elucidate the compound's mechanism of action at a molecular level. For instance, nuclear magnetic resonance (NMR) spectroscopy has been instrumental in determining the precise arrangement of atoms within the molecule, while computational studies have predicted how Amthamine Dihydrobromide might bind to target proteins.

One of the most intriguing aspects of Amthamine Dihydrobromide is its potential application in targeted drug delivery systems. Researchers are exploring nanotechnology-based approaches to enhance the compound's efficacy by improving its solubility and targeting specificity. For example, encapsulating Amthamine Dihydrobromide within liposomes or polymeric nanoparticles has shown promise in delivering the drug directly to affected tissues while minimizing side effects.

The pharmacokinetic properties of Amthamine Dihydrobromide are also under intensive scrutiny. Studies have revealed that the compound exhibits a moderate half-life, allowing for sustained therapeutic effects with appropriate dosing regimens. Additionally, its metabolic pathways have been characterized, providing insights into how the body processes and eliminates Amthamine Dihydrobromide. This information is crucial for optimizing dosages and minimizing potential adverse reactions.

Recent advancements in genetic engineering have opened new avenues for utilizing Amthamine Dihydrobromide in gene therapy applications. By combining the compound with viral vectors or non-viral delivery systems, researchers aim to correct genetic anomalies that contribute to various diseases. Preliminary results suggest that Amthamine Dihydrobromide can enhance the efficiency of these delivery systems, thereby improving therapeutic outcomes.

The synthesis of Amthamine Dihydrobromide has also seen significant innovations. Modern synthetic methodologies, such as catalytic hydrogenation and asymmetric synthesis, have enabled more efficient and scalable production processes. These advancements not only reduce costs but also improve the purity of the final product, ensuring higher reliability in research and clinical applications.

The regulatory landscape for Amthamine Dihydrobromide is evolving alongside these scientific breakthroughs. Regulatory agencies are increasingly recognizing the importance of novel compounds like Amthamine Dihydrobromide and are streamlining pathways for their approval. This trend bodes well for accelerating the transition from laboratory research to clinical use, ultimately benefiting patients who suffer from conditions that currently lack effective treatments.

In conclusion, Amthamine Dihydrobromide (CAS No. 142457-00-9) stands as a testament to the ongoing progress in chemical and biomedical research. Its multifaceted applications, from modulating cellular pathways to enhancing drug delivery systems, underscore its significance as a research tool and potential therapeutic agent. As scientists continue to uncover new insights into its properties and mechanisms, Amthamine Dihydrobromide is poised to play an increasingly vital role in addressing some of today's most pressing medical challenges.

• 18193-59-4(5-Isopropyl-4-methylthiazole-2-ylamine)
• 86029-68-7(2-Amino-4,5,6,7,8-pentahydrothiazolo5,4-dazepine)
• 45865-42-7(5-tert-Butyl-4-methyl-1,3-thiazol-2-amine)
• 61764-32-7(5-Ethyl-4-methylthiazol-2-amine)
• 36085-64-0(2-Amino-4,5,6,7,8-pentahydrothiazolo5,4-dazepine Dihydrochloride)
• 1820-94-6(5-Thiazoleethanol,2-amino-4-methyl-)
• 15913-44-7(2-Thiazolamine,5-(2-chloroethyl)-4-methyl-, hydrochloride (1:1))
• 142437-67-0(Amthamine)
• 105955-86-0(2-Thiazolamine,4,5-diethyl-)
• 15964-04-2(5-(2-chloroethyl)-4-methyl-2-Thiazolamine)